Insider Trading activities at Immix Biopharma, Inc. (IMMX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immix Biopharma, Inc. (IMMX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immix Biopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1873835.

Total stock buying since 2021: $1,219,587.
Total stock sales since 2021: $550.
Total stock option exercises since 2021: $0.


9 insiders reported insider trading activities at Immix Biopharma, Inc. (IMMX):
Insider trading activities of Morris Gabriel S
Insider trading activities of Buchan Melissa Jane
Insider trading activities of Senn Sean
Insider trading activities of Hsu Jason
Insider trading activities of Marquet Magda
Insider trading activities of Torchilin Vladimir P
Insider trading activities of Adams Helen C.
Insider trading activities of Ng Carey
Insider trading activities of Rachman Ilya M

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Immix Biopharma, Inc. (IMMX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 4,403 $10,068 0 $0 0 $0
2024 62,800 $132,222 0 $0 0 $0
2023 201,000 $654,963 0 $0 0 $0
2022 0 $0 200 $550 0 $0
2021 84,700 $422,334 0 $0 0 $0

Table 2. Monthly summary of insider trading at Immix Biopharma, Inc. (IMMX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-06 4,403 $10,068 0 $0 0 $0
2024-08 33,100 $70,223 0 $0 0 $0
2024-07 9,200 $19,516 0 $0 0 $0
2024-06 11,700 $22,777 0 $0 0 $0
2024-05 8,800 $19,706 0 $0 0 $0
2023-12 56,000 $266,919 0 $0 0 $0
2023-09 144,000 $386,035 0 $0 0 $0
2023-08 1,000 $2,009 0 $0 0 $0
2022-07 0 $0 200 $550 0 $0
2021-12 84,700 $422,334 0 $0 0 $0

Table 3. Detailed insider trading at Immix Biopharma, Inc. (IMMX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-06-18 Morris Gabriel S (CFO) Buy 2,225 2.28 5,070
2025-06-18 Rachman Ilya M (CEO and Chairman) Buy 2,178 2.29 4,998
2024-08-22 Hsu Jason Buy 8,100 2.25 18,233
2024-08-21 Hsu Jason Buy 15,000 2.23 33,390
2024-08-16 Ng Carey Buy 10,000 1.86 18,600
2024-07-24 Hsu Jason Buy 6,000 2.15 12,876
2024-07-18 Hsu Jason Buy 3,200 2.08 6,640
2024-06-07 Morris Gabriel S (CFO) Buy 2,500 2.12 5,297
2024-06-07 Rachman Ilya M (CEO and Chairman) Buy 2,600 2.13 5,538
2024-06-04 Morris Gabriel S (CFO) Buy 3,300 1.81 5,973
2024-06-04 Rachman Ilya M (CEO and Chairman) Buy 3,300 1.81 5,969
2024-05-14 Morris Gabriel S (CFO) Buy 4,500 2.23 10,044
2024-05-14 Rachman Ilya M (CEO and Chairman) Buy 4,300 2.25 9,662
2023-12-11 Hsu Jason Buy 31,000 4.67 144,894
2023-12-08 Hsu Jason Buy 25,000 4.88 122,025
2023-09-15 Hsu Jason Buy 7,000 2.48 17,395
2023-09-14 Hsu Jason Buy 10,000 2.58 25,770
2023-09-14 Ng Carey Buy 10,000 2.58 25,760
2023-09-12 Hsu Jason Buy 30,000 2.83 84,870
2023-09-12 Adams Helen C. Buy 13,000 2.96 38,493
2023-09-11 Hsu Jason Buy 25,000 2.89 72,275
2023-09-08 Hsu Jason Buy 10,000 2.53 25,320
2023-09-07 Buchan Melissa Jane Buy 20,000 2.46 49,220
2023-09-06 Marquet Magda Buy 9,000 2.47 22,212
2023-09-05 Marquet Magda Buy 10,000 2.47 24,720
2023-08-31 Marquet Magda Buy 1,000 2.01 2,009
2022-07-14 Senn Sean Sale 200 2.75 550
2021-12-20 Hsu Jason Buy 50,000 5.00 250,000
2021-12-20 Morris Gabriel S (Chief Financial Officer) Buy 2,000 5.00 10,000
2021-12-20 Torchilin Vladimir P (Scientific Co-Founder) Buy 3,000 5.00 15,000
2021-12-20 Ng Carey Buy 25,000 5.00 125,000
2021-12-20 Rachman Ilya M (CEO and Chairman) Buy 2,500 5.00 12,500
2021-12-17 Torchilin Vladimir P (Scientific Co-Founder) Buy 2,200 4.47 9,834

Insider trading activities including stock purchases, stock sales, and option exercises of IMMX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immix Biopharma, Inc. (symbol IMMX, CIK number 1873835) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.